Eylea contains human antibody fragment, known for its ability to prevent new blood vessels from forming under the retina. Use this injectable eye drug to treat wet age-related macular degeneration, retinal swelling from blood vessel blockage, diabetic retinopathy, and other eye diseases. Administer this ophthalmic injection to prevent blood and fluid leakage under the retina.
EYLEA® NON-ENGLISH
OphthalmologyProduct: EYLEA® 40mg/1ml Non-English
Manufacturer: Bayer
Active Substance(s): Aflibercept
Strength: 4mg
Pack Size: 1-100microliter vial
Accessories: Package insert, 1-18G needle
$1,369.00
